ASSET | DATE | % RETURN |
---|---|---|
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) | 12/28/2023 - 1/8/2024 | 76.47% |
Barnes & Noble Education (BNED) | 12/28/2023 - 1/8/2024 | 68.07% |
Akso Health Group ADR (AHG) | 12/28/2023 - 1/8/2024 | 51.16% |
NRx Pharmaceuticals (NRXPW) | 12/28/2023 - 1/8/2024 | 45.83% |
Yirendai (YRD) | 12/28/2023 - 1/8/2024 | 41.67% |
Inuvo (INUV) | 12/28/2023 - 1/8/2024 | 38.71% |
Clene (CLNNW) | 12/28/2023 - 1/8/2024 | 38.44% |
Praxis Precision Medicines (PRAX) | 12/28/2023 - 1/8/2024 | 36.03% |
Arcutis Biotherapeutics (ARQT) | 12/28/2023 - 1/8/2024 | 34.55% |
Aeva Technologies, Inc Common Stock (AEVA) | 12/28/2023 - 1/8/2024 | 34.48% |
Akebia Ther (AKBA) | 12/28/2023 - 1/8/2024 | 33.05% |
Dyne Therapeutics (DYN) | 12/28/2023 - 1/8/2024 | 32.57% |
Corvus Pharmaceuticals (CRVS) | 12/28/2023 - 1/8/2024 | 32.35% |
ATAI Life Sciences (ATAI) | 12/28/2023 - 1/8/2024 | 29.49% |
Keros Therapeutics (KROS) | 12/28/2023 - 1/8/2024 | 27.18% |
Iovance Biotherapeutics (IOVA) | 12/28/2023 - 1/8/2024 | 26.79% |
Abacus Life (ABL) | 12/28/2023 - 1/8/2024 | 26.12% |
Ardelyx (ARDX) | 12/28/2023 - 1/8/2024 | 25.65% |
Heron Therapeuti (HRTX) | 12/28/2023 - 1/8/2024 | 25.15% |
QuantaSing Group Limited American Depositary Shares (QSG) | 12/28/2023 - 1/8/2024 | 25% |
Aquestive Therapeutics (AQST) | 12/28/2023 - 1/8/2024 | 25% |
Axogen (AXGN) | 12/28/2023 - 1/8/2024 | 23.78% |
Nutex Health (NUTX) | 12/28/2023 - 1/8/2024 | 23.08% |
Spyre Therapeutics (SYRE) | 12/28/2023 - 1/8/2024 | 23.02% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 12/28/2023 - 1/8/2024 | 22.87% |